Value through Innovation27 July 2016

What is a lay summary?

To view this video in other translations click on the language below:
Chinese (simplified)
Chinese (traditional)
French
German
Italian
Japanese
Portuguese (Brazilian)
Spanish

Clinical Study Results

  • MENOFEM ® - Menopause
    Clinical Study Number 563.1
    Study Indication Menopause
    Product MENOFEM ®
    Generic Name Cimicifuga rhizome extract
    Lab Code
    Clinical Phase III
    Study Title

    Double-blind dose/response study comparing Klimadynon® with conjugated oestrogens in women suffering from menopausal complaints

    Study Document
    Trial synopsis 563.1 english
  • MENOFEM ® - Menopause
    Clinical Study Number 563.3
    Study Indication Menopause
    Product MENOFEM ®
    Generic Name Cimicifuga rhizome extract
    Lab Code
    Clinical Phase IV
    Study Title

    A prospective, open label, multicentre study to investigate the endometrial safety of Menofem® FCT during 52 weeks of administration in post-menopausal women suffering from symptoms related to estrogen deficiency.

    Study Document
    Trial synopsis 563.3 english